Factors influencing response to interferon in chronic hepatitis B: Implications for Asian and western populations
Open Access
- 1 December 1990
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 12 (6) , 1433-1435
- https://doi.org/10.1002/hep.1840120626
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Hepatitis B–Related SequelaeArchives of internal medicine (1960), 1990
- Mechanisms of Action of InterferonsSeminars in Liver Disease, 1989
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- Prednisone Withdrawal Followed by Recombinant Alpha Interferon in the Treatment of Chronic Type B HepatitisAnnals of Internal Medicine, 1988
- Adenine Arabinoside Monophosphate (Vidarabine Phosphate) in Combination with Human Leukocyte Interferon in the Treatment of Chronic Hepatitis BAnnals of Internal Medicine, 1987
- Controlled clinical trial of acyclovir in chronic hepatitis B virus infectionJournal of Medical Virology, 1987
- HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection†Hepatology, 1986
- A Short Course of Prednisolone in Chronic Type B HepatitisAnnals of Internal Medicine, 1986
- Comparative efficacy of adenine arabinoside 5′ monophosphate and prednisone withdrawal followed by adenine arabinoside 5′ monophosphate in the treatment of chronic active hepatitis type BGastroenterology, 1985